Cardiac resynchronisation therapy and the role of optimal device utilisation [0.03%]
心脏再同步治疗及最佳设备应用的作用
S Buck,A H Maass,D J van Veldhuisen et al.
S Buck et al.
Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17...
Non-bacterial thrombotic endocarditis in metastatic caecal adenocarcinoma [0.03%]
升结肠腺癌转移引起的非细菌性血栓性心内膜炎
J H Hofstra,J R Timmer,A Breeman et al.
J H Hofstra et al.
J C Vis,K van Engelen,J Timmermans et al.
J C Vis et al.
Down syndrome is the most common chromosomal abnormality. A simultaneous occurrence with Marfan syndrome is extremely rare. We present a case of a 28-year-old female with Down syndrome and a mutation in the fibrillin-1 gene. The patient sho...
Cardiopulmonary exercise testing in congenital heart disease: equipment and test protocols [0.03%]
先天性心脏病患者的 cardiopulmonary 运动试验：设备和测试方法
T Takken,A C Blank,E H Hulzebos et al.
T Takken et al.
Cardiopulmonary exercise testing (CPET) in paediatric cardiology differs in many aspects from the tests as performed in adult cardiology. Children's cardiovascular responses during exercise testing present different characteristics, particu...
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism [0.03%]
波生坦治疗肺动脉高压的效果与先天性心脏病和慢性肺栓塞的关联性研究比较
M G J Duffels,M N van der Plas,S Surie et al.
M G J Duffels et al.
Background. In patients with pulmonary hypertension, it is unknown whether the treatment effect of bosentan is dependent on the duration of pulmonary vessel changes. Therefore, we studied the response to bosentan in patients with life-long ...
Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension [0.03%]
波生坦治疗不可手术的慢性血栓栓塞性肺动脉高压患者的长期疗效
M C Post,H W M Plokker,J C Kelder et al.
M C Post et al.
Background. Inoperable chronic thromboembolic pulmonary hypertension (CTEPH) is associated with a poor survival.Objectives. To evaluate the long-term response to a dual endothelin receptor antagonist in patients with inoperable CTEPH.Method...
RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results [0.03%]
RESPONSE研究：心梗二级预防门诊护士专家随机评估研究设计、目的和预期结果
H T Jørstad,A M W Alings,A H Liem et al.
H T Jørstad et al.
Background. Patients with coronary artery disease are at high risk of coronary events and death, but effective secondary prevention can reduce this risk. There is a gap between guidelines on secondary prevention and the implementation of th...
H Koppen,G M Terwindt,J Haan et al.
H Koppen et al.